GussinHAIgnatGPVargaJDeodorescuM. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum2001; 44: 376–383.
2.
MahlerMSilvermanEDShulte-PelkumJFrizlerMJ. Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality?Autoimmun Rev2010; 9: 756–760.
3.
HamidouMAAudrainMAMasseauAAqardCMoreauA. Antitopoisomerase-I in systemic lupus erythematosus as a marker of severe nephritis. Clin Rheumatol2006; 25: 542–543.
4.
SimonDCzömpölyTBerkiTet al.Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus. Int Immunol2009; 21: 415–422.
5.
BentowCSwartAWuJet al.Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens. Clin Chim Acta2013; 424: 141–147.
6.
FrediMCavazzanaIQuinzaniniMet al.Rare autoantibodies to cellular antigens in systemic lupus erythematosus. Lupus2014; 23: 672–677.
